Literature DB >> 34301330

Submandibular lymph node metastasis of occult thyroid carcinoma first suspected to be a salivary gland tumor: a case report.

Hiroyuki Kaneko1, Mami Deguchi2, Hisashi Yano2.   

Abstract

BACKGROUND: When diagnosing and treating neck masses, various diseases need to be considered, including benign or malignant tumors, lymph node-related diseases, and cysts. Thus, there may be cases in which making a definitive diagnosis is difficult on the basis of blood testing and imaging alone. CASE
PRESENTATION: The patient was an 80-year-old Japanese female who presented with swelling in the right submandibular area. Magnetic resonance imaging and ultrasonography revealed a solid tumor with inhomogeneous content continuous with the submandibular gland. Therefore, the clinical diagnosis was salivary gland tumor. Surgical treatment was performed, and intraoperative frozen-section examination demonstrated submandibular lymph node metastasis of thyroid carcinoma. After surgical treatment, blood test for thyroid gland function yielded normal results except for increased thyroglobulin levels. Further positron-emission tomography-computed tomography and ultrasonography were performed, in addition to fine-needle aspiration biopsy of the thyroid gland and other tests; however, no other thyroid abnormalities were observed. Fine-needle aspiration biopsy revealed no carcinomatous components. Close observational follow-up has been continued without thyroid gland treatment, and as of approximately 8 years postoperation, no recurrence, metastases, or thyroid carcinoma have developed.
CONCLUSION: The mass was lymph node metastasis of occult thyroid carcinoma. In general, occult thyroid carcinoma metastasizes to level II-V. To the best of our knowledge, this is the first report of submandibular lymph node metastasis alone of occult thyroid carcinoma.
© 2021. The Author(s).

Entities:  

Keywords:  Neck masses; Occult thyroid carcinoma; Papillary thyroid carcinoma; Submandibular lymph node

Year:  2021        PMID: 34301330     DOI: 10.1186/s13256-021-02901-7

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  3 in total

Review 1.  Occult thyroid carcinoma.

Authors:  J Boucek; J Kastner; J Skrivan; E Grosso; B Gibelli; G Giugliano; J Betka
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

2.  The value of PET compared to MRI in malignant head and neck tumors.

Authors:  Thomas Guenzel; Achim Franzen; Susanne Wiegand; Sabine Kraetschmer; Johann Ludwig Jahn; Robert Mironczuk; Thomas Wilhelm; Thomas Schrom
Journal:  Anticancer Res       Date:  2013-03       Impact factor: 2.480

3.  Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.

Authors:  U Feine; R Lietzenmayer; J P Hanke; J Held; H Wöhrle; W Müller-Schauenburg
Journal:  J Nucl Med       Date:  1996-09       Impact factor: 10.057

  3 in total
  1 in total

Review 1.  Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.

Authors:  Andrigo Barboza de Nardi; Rodrigo Dos Santos Horta; Carlos Eduardo Fonseca-Alves; Felipe Noleto de Paiva; Laís Calazans Menescal Linhares; Bruna Fernanda Firmo; Felipe Augusto Ruiz Sueiro; Krishna Duro de Oliveira; Silvia Vanessa Lourenço; Ricardo De Francisco Strefezzi; Carlos Henrique Maciel Brunner; Marcelo Monte Mor Rangel; Paulo Cesar Jark; Jorge Luiz Costa Castro; Rodrigo Ubukata; Karen Batschinski; Renata Afonso Sobral; Natália Oyafuso da Cruz; Adriana Tomoko Nishiya; Simone Crestoni Fernandes; Simone Carvalho Dos Santos Cunha; Daniel Guimarães Gerardi; Guilherme Sellera Godoy Challoub; Luiz Roberto Biondi; Renee Laufer-Amorim; Paulo Ricardo de Oliveira Paes; Gleidice Eunice Lavalle; Rafael Ricardo Huppes; Fabrizio Grandi; Carmen Helena de Carvalho Vasconcellos; Denner Santos Dos Anjos; Ângela Cristina Malheiros Luzo; Julia Maria Matera; Miluse Vozdova; Maria Lucia Zaidan Dagli
Journal:  Cells       Date:  2022-02-10       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.